See What HealthDay Can Do For You
Contact Us

Short-Course Antibiotics Noninferior for Pediatric Pneumonia

Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia

prescription bottle

WEDNESDAY, March 10, 2021 (HealthDay News) -- Five days of antibiotic therapy is noninferior to standard care for treatment of children with community-acquired pneumonia (CAP), according to a study published online March 8 in JAMA Pediatrics.

Jeffrey M. Pernica, M.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a noninferiority trial involving 281 children aged 6 months to 10 years with CAP who received five days of high-dose amoxicillin therapy followed by five days of placebo (intervention) or five days of high-dose amoxicillin followed by five days of a different formulation of high-dose amoxicillin (control group).

The researchers found that 88.6 percent of children in the intervention group and 90.8 percent in the control group had clinical cure in the per-protocol analysis (risk difference, −0.016; 97.5 percent confidence limit, −0.087). At 14 to 21 days, clinical cure was observed in 85.7 and 84.1 percent of the intervention and control groups, respectively, in the intention-to-treat analysis (risk difference, 0.023; 97.5 percent confidence limit, −0.061).

"Several studies have proven that adults with pneumonia do fine with short courses of antibiotics, and now we have proved a short course of antibiotics also works for children," Pernica said in a statement. "The dramatic increase in antimicrobial resistance in the world today is driven by overuse of antibiotics -- which has only worsened during the COVID-19 pandemic. This is why we need these clinical studies -- to figure out how short we can make antibiotic treatment courses for common infections."

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.